IL10 and type 1 diabetes mellitus: Major histocompatibility complex II of the T1D resistance haplotype reportedly presents islet antigens (suppressive antigens) to regulatory T cells (Tregs), thereby promoting the production of anti-inflammatory cytokines such as interleukin 10 and suppressing the activity of autoreactive islet-responsive T cells [12].